All In Biotech

Drug Trial Radar · NCT00486031

Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study

A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis

Last checked: Nov 20, 2026Latest source record: Aug 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

443

Actual

Start

Oct 2006

Primary completion

Apr 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Jun 13, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative colitis or who have mildly to moderately active UC.

Conditions

  • Inflammatory Bowel Disease
  • Ulcerative Colitis

Interventions

  • Balsalazide DisodiumDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment Emergent AEsTime frame: 24 Months

Locations

95 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham Gastroenterology Associates, PC

    Birmingham, Alabama

  • Premeire Pharmaceutical Research

    Tempe, Arizona

  • Medical Services of NWA

    Fayetteville, Arkansas

  • AGMG Clinical Research Institute

    Anaheim, California

  • Discovery Clinical Research, Inc.

    Encinitas, California

  • Digestive and Liver Disease Specialists

    Garden Grove, California

  • West Gastroenterology Medical Group

    Los Angeles, California

  • Community Clinical Trials

    Orange, California

  • Sharp Rees-Stealy Medical

    San Diego, California

  • Rocky Mountain Gastroenterology

    Lakewood, Colorado

  • Arapahoe Gastrroenterology, PC

    Littleton, Colorado

  • South Denver Gastroenterology

    Lone Tree, Colorado

  • Connecticut Gastroenterology Institute

    Bristol, Connecticut

  • Clinical Trials Management of Boca Raton

    Boca Raton, Florida

  • Research Consultants Group

    Hialeah, Florida

  • Horizon Institute for Clinical Research

    Hollywood, Florida

  • Mark Lamet, M.D.

    Hollywood, Florida

  • Southern Clinical Research Consultants

    Hollywood, Florida

  • A+ Research

    Miami, Florida

  • United Medical Research

    New Smyrna Beach, Florida

  • Venture Research Institute, LLC

    North Miami Beach, Florida

  • West Wind'r Research & Development

    Tampa, Florida

  • Shafran Gastroenterology Center

    Winter Park, Florida

  • Florida Medical Clinic, PA

    Zephyrhills, Florida

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia

  • Dekalb Gastroenterology Associates

    Decatur, Georgia

  • Gastroenterology Associates of Central Georgia

    Macon, Georgia

  • Digestive Research Associates

    Newnan, Georgia

  • University Digestive Health Center

    Oak Forest, Illinois

  • Carle Clinic Association

    Urbana, Illinois

  • Community Clinical Research Center

    Anderson, Indiana

  • Iowa Digestive Disease Center, PC

    Clive, Iowa

  • Cotton-O'Neil Digestive Health Center

    Topeka, Kansas

  • Digestive Health Center of Louisiana

    Baton Rouge, Louisiana

  • Clinical Trials Management

    Metairie, Louisiana

  • Digestive Disorders Associates

    Annapolis, Maryland

  • Alan Rosen, M.D.

    Baltimore, Maryland

  • Digestive Disease Association

    Baltimore, Maryland

  • Metro Gastroenterology Group

    Chevy Chase, Maryland

  • Washington County Hospital

    Hagerstown, Maryland

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.